Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.63, sa.2, ss.94-101, 2015 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 63 Sayı: 2
- Basım Tarihi: 2015
- Doi Numarası: 10.5578/tt.9110
- Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.94-101
- Anahtar Kelimeler: Community acquired pneumonia, ampicilline-sulbactam, fluoroquinolone
- Akdeniz Üniversitesi Adresli: Evet
Özet
Introduction: For hospitalized patients, monotherapy with a respiratory Fluoroquinolone (F) and dual therapy combination a ampicilline-sulbactam + a macrolide (AS+ M) are extensively used in the treatment of community-acquiredpneumonia (CAP). In this study, empirical AS + M combination therapy versus F monotherapy was compared in hospitalized adult CAP patients.